Segment disclosures

Company overview

에이프로젠바이오로직스

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 49 retained observations 33 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Consolidated

Consolidated And Separate Financial Statements

Source dimensions ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-3023078438870 KRW20260813Open filing evidence
2026-01-01 – 2026-06-3044698557114 KRW20260813Open filing evidence
2026-01-01 – 2026-03-3121620118244 KRW20260514Open filing evidence
2025-01-01 – 2025-12-3173226140158 KRW20260320Open filing evidence
2025-07-01 – 2025-09-3021118193903 KRW20251113Open filing evidence
2025-01-01 – 2025-09-3052862334133 KRW20251113Open filing evidence
2025-04-01 – 2025-06-3014896234814 KRW20260813Open filing evidence
2025-01-01 – 2025-06-3031744140230 KRW20260813Open filing evidence
2025-01-01 – 2025-03-3116847905416 KRW20260514Open filing evidence
2024-01-01 – 2024-12-3167378141310 KRW20260320Open filing evidence
2024-07-01 – 2024-09-3014531179157 KRW20251113Open filing evidence
2024-01-01 – 2024-09-3045329076048 KRW20251113Open filing evidence
2024-04-01 – 2024-06-3015191585418 KRW20250813Open filing evidence
2024-01-01 – 2024-06-3030797896891 KRW20250813Open filing evidence
2024-01-01 – 2024-03-3115606311473 KRW20250514Open filing evidence
2023-01-01 – 2023-12-3187363627712 KRW20260320Open filing evidence
2023-07-01 – 2023-09-3020133627604 KRW20241113Open filing evidence
2023-01-01 – 2023-09-3064660150776 KRW20241113Open filing evidence
2023-04-01 – 2023-06-3027074579990 KRW20240814Open filing evidence
2023-01-01 – 2023-06-3044526523172 KRW20240814Open filing evidence
2023-01-01 – 2023-03-3117451943182 KRW20240514Open filing evidence
2022-01-01 – 2022-12-3165190359336 KRW20250314Open filing evidence
2022-07-01 – 2022-09-3016016325658 KRW20231113Open filing evidence
2022-01-01 – 2022-09-3048106019185 KRW20231113Open filing evidence
2022-04-01 – 2022-06-3015226835653 KRW20230814Open filing evidence
2022-01-01 – 2022-06-3032089693527 KRW20230814Open filing evidence
2022-01-01 – 2022-03-3116862857874 KRW20230512Open filing evidence
2021-01-01 – 2021-12-3156481701589 KRW20240313Open filing evidence
2021-07-01 – 2021-09-3014665671615 KRW20221111Open filing evidence
2021-01-01 – 2021-09-3042106991572 KRW20221111Open filing evidence
2021-04-01 – 2021-06-3015159660989 KRW20220812Open filing evidence
2021-01-01 – 2021-06-3027441319957 KRW20220812Open filing evidence
2021-01-01 – 2021-03-3112281658968 KRW20220513Open filing evidence
2020-01-01 – 2020-12-3153319976202 KRW20230317Open filing evidence
2020-07-01 – 2020-09-3013412177895 RestatedKRW20211111Open filing evidence
2020-01-01 – 2020-09-3040745035098 KRW20211111Open filing evidence
2020-04-01 – 2020-06-3013493441083 KRW20210813Open filing evidence
2020-01-01 – 2020-06-3027332857203 KRW20210813Open filing evidence
2020-01-01 – 2020-03-3113839416120 KRW20210514Open filing evidence
2019-01-01 – 2019-12-3150903820545 KRW20220314Open filing evidence
2019-07-01 – 2019-09-3012132622048 KRW20201117Open filing evidence
2019-01-01 – 2019-09-3036160827977 KRW20201117Open filing evidence
2019-04-01 – 2019-06-3012735737870 KRW20200813Open filing evidence
2019-01-01 – 2019-06-3024028205929 KRW20200813Open filing evidence
2019-01-01 – 2019-03-3111292468059 KRW20200514Open filing evidence
2018-01-01 – 2018-12-3145395389395 KRW20210318Open filing evidence
2018-07-01 – 2018-09-3010465908512 KRW20191113Open filing evidence
2018-01-01 – 2018-09-3032401067023 KRW20191113Open filing evidence
2017-01-01 – 2017-12-3146100951698 KRW20200327Open filing evidence